Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 2: metabolism-directed optimization studies towards orally bioavailable derivatives.
The synthesis and optimization of pharmacokinetic parameters of structurally novel small PDE7 inhibitors is discussed.